Profound Medical Corp T.PRN

Alternate Symbol(s): PROF

Healthcare Medical Devices

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

TSX:PRN - Post by User

Profound Medical Corp > Ink Research

<< Previous

Bullboard Posts

Next >>

Comment by HomerAndCompanyon Jun 20, 2021 9:02am

150 Views

Post# 33417695

RE:Ink Research

Arun Menawat, CEO also bought 5,000 shares May 20, now holding 246,988 shares.

retiredcf wrote:

Most active public-market buying insiders (all markets in Canada)
From May 17th to May 21st as filed and reported by mid-day May 24th (000's):

Samir Manji bought $2,410 Artis REIT (Mostly Sunny; AX.UN)
Eric Sprott, via 2176423 Ontario, bought $2,232 New Found Gold (Sunny; NFG) Linda Heathcott bought $1,496 ATCO (Sunny; ACO)
Ewan Downie bought $492 i-80 Gold (IAU)
Brian Ellacott bought $387 Profound Medical (Rainy; PRN)